LFCR Lifecore Biomedical Inc. Company Projected Revenue

Lifecore Biomedical (LFCR) planned sales levels demonstrate resilience driven by strict FDA oversight and patent protection. Lifecore Biomedical (LFCR) revenues are based on the production of hyaluronic acid and sterile fill-finish services. Predictive monitoring of raw material inventories ensures operational stability. The current level of 0.00 captures fresh values, allowing for an objective assessment of the asset's fundamental value during periods of market volatility.

LFCR - Lifecore Biomedical Company Future Sales over the range 04/28/2023 - 11/13/2026

Summary analytical data breakdowns for Lifecore (LFCR)

- stock value and consensus price forecast:

Price Chart Lifecore Biomedical|LFCR - Analyst Median Target

- market capitalization data:

Market Value Lifecore Biomedical Inc.|LFCR - Total Company Value

- balance sheet equity data:

Book Value per Share Lifecore Biomedical|LFCR - Book Valuation of Business|Market Capitalization to Book Value Ratio lifecore.com|LFCR - Total Asset Value of Company

- debt obligations and liquidity statistics:

- earnings and market ratios statistics:

LFCR - Company Net Income|Future Profit Lifecore Biomedical|LFCR - Company Value to Net Income|Forward P/E Multiple Lifecore Biomedical|LFCR - Price/Earnings to Growth Ratio|EV/EBITDA Multiple Lifecore Biomedical Inc.|LFCR - Operating income before deduction of amortization|Earnings per share for the last twelve months Lifecore Biomedical|LFCR - Net earnings per one share for the last twelve months|Year-over-year earnings per share growth for the last twelve months lifecore.com|LFCR - Net earnings per share growth this year|Earnings growth forecast for next year Lifecore Biomedical

- revenue and sales proceeds data:

LFCR - Company Total Revenue|Projected Sales Volume Lifecore Biomedical|LFCR - Market Cap to Revenue Ratio|Forward P/S Multiple Lifecore Biomedical Inc.

Fundamental company analysis:LFCR Lifecore Biomedical, Inc.

This indicator synthesizes the market expectations of traders, converting current quotes into a leading forecast of future revenue to assess the fundamental value of the business. For Lifecore Biomedical (LFCR), whose model is based on stable long-term biopharmaceutical contracts, analyzing the sales volume forecast allows for the timely identification of structural shifts in demand while ignoring short-term market noise.

Competitors of Lifecore Biomedical (LFCR)